Trials / Not Yet Recruiting
Not Yet RecruitingNCT06974097
Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 72 (estimated)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
evaluate the predictive value of circulating neutrophil DNA methylation profiles, identified from the ALCINA 2 cohort, on pre-treatment blood samples (T0), for the histological response to neoadjuvant chemo-immunotherapy in patients with resectable non-small cell lung cancer (NSCLC)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | blood sampling | blood sampling |
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2028-07-28
- Completion
- 2028-12-30
- First posted
- 2025-05-15
- Last updated
- 2025-07-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06974097. Inclusion in this directory is not an endorsement.